United Therapeutics (UTHR) Q2 2019 Earnings Report
MX:UTHR Q2 2019 EPS Results
- Actual EPS
- MXN 87.57
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- MXN 74.79
MX:UTHR Q2 2019 Revenue Results
- Actual Revenue
- MXN 7.02B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -15.95%
Earnings Announcement Details
- Quarter
- Q2 2019
- Date
- 07/31/2019
- Time
- Before Open
- Conference Call
- Wednesday, July 31, 2019
MX:UTHR Upcoming Earnings
United Therapeutics's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q2 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:UTHR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | 112.88- | 134.55 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 128.95136.62 | 120.46 | 13.42% (+16.16) | |
| May 06, 2026 | 2026 (Q1) | 131.51109.37 | 124.59 | -12.22% (-15.22) | |
| Feb 25, 2026 | 2025 (Q4) | 133.99144.70 | 116.32 | 24.39% (+28.38) | |
| Oct 29, 2025 | 2025 (Q3) | 137.50134.55 | 120.08 | 12.05% (+14.47) | |
| Jul 30, 2025 | 2025 (Q2) | 137.09120.46 | 109.93 | 9.57% (+10.52) | |
| Apr 30, 2025 | 2025 (Q1) | 125.83124.59 | 115.95 | 7.46% (+8.64) | |
| Feb 26, 2025 | 2024 (Q4) | 120.27116.32 | 81.93 | 41.97% (+34.39) | |
| Oct 30, 2024 | 2024 (Q3) | 122.58120.08 | 101.1 | 18.77% (+18.98) | |
| Jul 31, 2024 | 2024 (Q2) | 122.24109.93 | 98.47 | 11.64% (+11.46) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
